GDF15 and colorectal cancer: Thus, for those agents that have benign side effect profiles, there might be potential that they could be used in combination with a GDF15 inhibitor for the prevention or treatment of colorectal cancer in the future (Baek et al., 2009; Bauskin et al., 2006; Roth et al., 2010).